Investigators trained and validated a deep-learning AI model to identify patients with high-risk NMIBC unlikely to benefit from BCG. Artificial intelligence (AI)-based histologic assays identify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback